Dopamine as a prolactin (PRL) inhibitor.

By N. Ben-Jonathan, R. Hnasko. Endocrine reviews, 2001

981 citations recorded by the source corpus.

Subfields: Endocrine and Autonomic Systems, Molecular Biology, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/ca80871600d25ee18777b73ddf0b8bc16a15a651

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. H. Migaud
2. L. Pogach
3. J. Taylor
4. S. R. Marder
5. Robert W. Buchanan
6. Alexander L. Miller
7. John M. Kane
8. Daniel E. Casey

Citations in the corpus

• Morphological skin colour changes in teleosts (2009, background): “Finally, dopamine is the primary inhibitor of both gonadotropes and PRL-releasing cells in teleosts (Ben-Jonathan and Hnasko 2001; Dufour et al. 2005).”
• Physical health monitoring of patients with schizophrenia. (2004, background): “Antipsychotic medications— particularly first-generation agents and risperidone—can cause hyperprolactinemia by their activity at dopamine D2 receptors that suppress the secretory activity of pituitary lactotrophs (52).”